Key result
Family studies identify prothrombin Molise as a new congenital dysprothrombinemia characterized by double heterozygosity.
Why the study?
A new congenital dysprothrombinemia with double heterozygosis involving abnormal prothrombin and true prothrombin deficiency was identified but not previously described.
Case Report (n=6)
The study identifies 'prothrombin Molise', a novel congenital dysprothrombinemia characterized by double heterozygosity for an abnormal prothrombin and true prothrombin deficiency.
Alerts clinicians to prothrombin Molise in bleeding evaluations; extends dysprothrombinemia spectrum but leaves management implications open.
A family with a new congenital dysprothrombinemia is described. The propositus was a 36-yr-old female from the Molise region of Italy who presented with epistaxis, easy bruising, and menometrorrhagia. The main laboratory features of the defect included slight prolongation of prothrombin time, Thrombotest, Normotest, PP test, and partial thromboplastin time. Prothrombin activity was approximately 10% in several one- and two-stage systems employing tissue thromboplastins as activating agents. Using several viper venoms as activating agents low prothrombin levels were also obtained. However, the staphylocoagulase-complexed prothrombin level and immunologic methods yielded levels of about 50%. A line of identity between normal and abnormal prothrombin was seen on immunodiffusion. The migration of the abnormal prothrombin was normal in single and bidimensional immunoelectrophoresis systems. A single abnormal serum fragment was seen on bidimensional immunoelectrophoresis. The brother of the propositus was also affected and presented a similar pattern. Family studies revealed that the mother had approximately 50% prothrombin activity and antigen, whereas the father had 65% prothrombin activity and 100% prothrombin antigen. The propositus's first son showed approximately 50% prothrombin activity and antigen. A second child showed approximately 50% prothrombin activity but normal antigen. We suggest that the propositi are heterozygous for an abnormal prothrombin and heterozygous for “true” prothrombin deficiency. The father and the second child are heterozygous for abnormal prothrombin. The mother and the first child are heterozygous for “true” prothrombin deficiency. The term prothrombin Molise is proposed for this peculiar prothrombin abnormality.
No takes yet. Share an insight, caveat, or question.
Girolami et al. (1978) conducted a case report in Congenital dysprothrombinemia (n=6). Prothrombin Molise (abnormal prothrombin and true prothrombin deficiency) was evaluated on Prothrombin activity and antigen levels. Family studies identified "prothrombin Molise," a new congenital dysprothrombinemia characterized by double heterozygosity for an abnormal prothrombin and true prothrombin deficiency.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: